PROGENICS PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 11244
 
  
 
C07D HETEROCYCLIC COMPOUNDS 8154
 
  
 
2402 MEDICAL INSTRUMENTS, INSTRUMENTS AND TOOLS FOR LABORATORY USE241
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
C07K PEPTIDES 1135

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9879024 Crystal forms of (R)-N-methylnaltrexone bromide and uses thereofAug 07, 15Jan 30, 18[A61K, C07D]
9669096 Stable pharmaceutical formulations of methylnaltrexoneSep 27, 13Jun 06, 17[A61K]
9597327 Synthesis of (R)-N-methylnaltrexoneJun 22, 15Mar 21, 17[A61K, C07D, G01N]
9102680 Crystal forms of (R)-N-methylnaltrexone bromide and uses thereofNov 21, 12Aug 11, 15[A61K, C07D]
8986697 -associated infection and diseaseApr 15, 11Mar 24, 15[A61K, C07K]
8916581 -methylnaltrexoneJun 23, 11Dec 23, 14[A61K, C07D]
8916706 Preparation and use of (R),(R)-2,2′-bis-methylnaltrexoneJun 06, 13Dec 23, 14[C07D, G01N]
D715422 Automatic injection deviceMay 18, 12Oct 14, 14[2402]
8853232 Peripheral opioid receptor antagonists and uses thereofSep 04, 13Oct 07, 14[A61K, C07D]
D714932 Automatic injection deviceMay 18, 12Oct 07, 14[2402]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0143,700 SYNTHESIS OF (R)-N-METHYLNALTREXONEAbandonedFeb 08, 17May 25, 17[A61K]
2015/0175,681 ANTIBODIES FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED INFECTION AND DISEASEAbandonedMar 09, 15Jun 25, 15[A61K, C07K]
2015/0057,303 SYNTHESIS OF (R)-N-METHYLNALTREXONEAbandonedMar 18, 14Feb 26, 15[A61K]
2015/0025,100 FORMULATIONS FOR PARENTERAL DELIVERY OF COMPOUNDS AND USES THEREOFAbandonedDec 13, 13Jan 22, 15[A61K]
2013/0323,286 SYNTHESIS OF R-N-METHYLNALTREXONEAbandonedNov 07, 12Dec 05, 13[A61K, C07D, G01N]
8546418 Peripheral opioid receptor antagonists and uses thereofExpiredMar 28, 08Oct 01, 13[A61K, C07D]
8471022 Preparation and use of (R),(R)-2,2′-bis-methylnaltrexoneExpiredFeb 06, 08Jun 25, 13[C07D]
2012/0009,151 Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods ThereofAbandonedDec 19, 08Jan 12, 12[A01P, A61K, A01N, C07D, C12N, A61P]
2011/0212,053 PHOSPHATIDYLINOSITOL 3 KINASE INHIBITORSAbandonedJun 19, 09Sep 01, 11[A61K, C07D, C12N, A61P]
7939083 Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomainExpiredOct 17, 07May 10, 11[A61K]
2011/0076,298 Soluble stabilized trimeric hiv env proteins and uses thereofAbandonedJun 19, 07Mar 31, 11[A61K, C07H, C12N, A61P, C07K]
2010/0305,323 CRYSTAL FORMS OF (R)-N-METHYLNALTREXONE BROMIDE AND USES THEREOFAbandonedMar 28, 08Dec 02, 10[C07D]
2010/0267,758 PHARMACEUTICAL FORMULATIONAbandonedDec 16, 09Oct 21, 10[A61K, A61P]
2010/0261,745 PHARMACEUTICAL FORMULATIONAbandonedDec 16, 09Oct 14, 10[A61K, A61P]
2010/0261,746 PHARMACEUTICAL FORMULATIONAbandonedDec 16, 09Oct 14, 10[A61K, A61P]
7592014 Stabilized viral envelope proteins and uses thereofExpiredOct 28, 05Sep 22, 09[A61K]
7563899 -methylnaltrexoneExpiredMay 25, 06Jul 21, 09[C07D]
2009/0155,774 Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cellAbandonedFeb 17, 09Jun 18, 09[C12Q]
2009/0074,766 Methods of inhibiting HIV-2 infectionAbandonedSep 12, 08Mar 19, 09[A61K]
2009/0047,279 (R)-N-Stereoisomers of 7,8-Saturated-4,5-Epoxy-Morphinanium AnalogsAbandonedNov 21, 07Feb 19, 09[A61K, C07D, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.